The Bone Mineral Densitometry (BMD) Market will witness a CAGR of 3.5%, reaching US$ 310.6 Mn between 2021-2031. With medical IoT implying the use of wearable monitors, devices, and various integrated applications regarding healthcare needs, the healthcare vertical is bound to scale new-fangled heights in the upcoming period. This is what the healthcare vertical would all be in the next 10 years.
The global bone mineral densitometry (BMD) market was valued at US$ 310.6 Mn in 2020, and is expected to exhibit a CAGR of around 3.5% over the forecast period (2021 – 2031).
Rise in prevalence of osteoporosis in the aged population and women aged above 50 has led to a surge in demand for bone mineral densitometry. Rising awareness about osteoporosis and efforts by various foundations are increasing awareness among the women population is leading to increased demand for bone densitometers globally.
Increasing number of spinal and hip fractures requiring bone mineral density scanning to avoid re-fractures is leading to higher installation of bone mineral densitometers in healthcare settings. Osteoporosis remains highly underdiagnosed and undertreated in South East Asia and many European countries.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/32513
There has been an increase in healthcare expenditure as well as reimbursements policies among developing nations, which is creating higher demand for bone densitometers. New product launches, acquisitions, and collaborations by key players are also expected to aid market expansion.
Company Profiles:
- GE Healthcare
- Hologic, Inc.
- Beammed, Ltd.
- Swissray International, Inc.
- Osteosys Co. Ltd.
- Diagnostic Medical System SA
- Medonica Co., Ltd.
- OsteometerMeditech
- Hitachi Ltd.
Request for Methodology @ https://www.persistencemarketresearch.com/methodology/32513
Key Takeaways from Market Study
- Axial bone densitometers hold over 68% value share, globally, as they are used for the detection of bone density in central sites, including the vertebral column, ribcage, and pelvic region.
- Dual X-ray absorptiometry (DXA) is preferred due to higher number of bone density detections at central skeletal sites as compared to peripheral.
- In terms of end user, hospitals contribute maximum share in the market due to higher footfall of patients as compared to other end-user facilities.
- North America remains dominant in the global market for bone mineral densitometers, and will continue to hold strong revenue share of more than 51% over the forecast period.
“BMD is witnessing growth in developed as well as emerging economies due to high prevalence of osteoporosis and osteoporotic fracture-related cases. Advancements in DXA technologies for higher precision and accuracy will lead a path toward improved diagnostic approaches to understand bone pathologies and preventing recurrent fractures,” says an analyst of Persistence Market Research.
Acquisitions and Collaborations – Strategy by Key Players
Key manufacturers of bone mineral densitometers are collaborating with domestic vendors to expand their channel partnerships and increase their regional and global presence.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/32513
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the bone mineral densitometry market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.
The research study is based on the product (axial bone densitometry and peripheral bone densitometry), technology (dual-energy X-ray absorptiometry (DXA), peripheral dual energy X-ray absorptiometry (pDXA), quantitative ultrasound (QUS), and others), and end user (hospitals, orthopaedic clinics, and diagnostic centers), across seven key regions of the world (North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa).
Access Related Reports:
E-Prescribing Market:
According to a new market report published by Persistence Market Research “Global Market Study on E-Prescribing: North America to Witness Highest Growth by 2019,” the global E-Prescribing market was valued at USD 250.2 million in 2013 and is expected to grow at a CAGR of 23.5% from 2013 to 2019, to reach an estimated value of USD 887.8 million in 2019.
Gene Expression Analysis Market:
According to the recently-published report by Persistence Market Research, the global market for gene expression analysis will reflect a steady growth during the forecast period, 2017-2022. By the end of 2022, the global gene expression analysis market is predicted to surpass US$ 4,500 Mn valuation, reflecting a robust CAGR in terms of revenues.
Botulinum Toxin Market:
Whether it is a 40+ woman worried about the wrinkles and fine lines on her skin or a patient suffering from chronic migraines and excessive sweating, the whole world swears by botulinum toxin as the ultimate go-to remedy that promises instant and long-lasting relief.
Orthopedic Veterinary Implants Market:
Increasing focus on pet health insurance is also identified as an important factor driving the market for orthopedic veterinary implants. The global orthopedic veterinary implants market will exhibit a robust CAGR of over 8% during the forecast period (2019 – 2029).
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com